EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Clinical Relevance of Epithelial-to-Mesenchymal Transition Hallmarks: A Cut-Off-Based Approach in Healthy and Cancerous Cell Lines

Maria Cristina Rapanotti, Elisa Cugini, Maria Giovanna Scioli iD, Tonia Cenci iD, Silvia Anzillotti iD, Martina Puzzuoli, Alessandro Terrinoni iD, Amedeo Ferlosio, Anastasia De Luca iD, Augusto Orlandi iD

International Journal of Molecular Sciences · 11.04.2025 · 26 (8) · 3617

DOI: 10.3390/ijms26083617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.04.2025. Verfasst von Maria Cristina Rapanotti und 9 weiteren Autor:innen. Beteiligte Einrichtung: Anatomic Pathology, Department of Integrated Care Processes, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The atypical activation of the epithelial-to-mesenchymal transition represents one of the main mechanisms driving cancer cell dissemination. It enables epithelial cancer cells to detach from the primary tumor mass and gain survival advantages in the bloodstream, significantly contributing to the spread of circulating tumor cells. Notably, epithelial-to-mesenchymal transition is not a binary process but rather leads to the formation of a wide range of cell subpopulations characterized by the simultaneous expression of both epithelial and mesenchymal markers. Therefore, analyzing the modulation of EMT hallmarks during the conversion from healthy cells to metastatic cancer cells, which acquire stem mesenchymal characteristics, is of particular interest. This study investigates the expression of a panel of epithelial-to-mesenchymal transition-related genes in healthy cells, primary and metastatic cancer cells, and in mesenchymal cell lines, derived from various tissues, including the lung, colon, pancreas, skin, and neuro-ectoderm, with the aim of identifying potential cut-off values for assessing cancer aggressiveness. Interestingly, we found that the expression levels of CDH1, which encodes the epithelial marker E-cadherin, CDH5, encoding vascular endothelial cadherin, and the epithelial-to-mesenchymal transition-transcription factor ZEB1, effectively distinguished primary from metastatic cancer cells. Additionally, our data suggest a tissue-specific signature in the modulation of epithelial-to-mesenchymal transition markers during cancer progression. Overall, our results underscore the importance of investigating epithelial-to-mesenchymal transition as a tissue-specific process to identify the most suitable markers acting as potential indicators of disease aggressiveness and therapeutic responsiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epithelial-Mesenchymal TransitionNeoplasmsHumansCell Line, TumorBiomarkers, TumorZinc Finger E-box-Binding Homeobox 1CadherinsGene Expression Regulation, NeoplasticClinical RelevanceAntigens, CD

Stichwörter der Autor:innen

cancerous cellsepithelial-to-mesenchymal transitionhealthy cellsmesenchymal cells

Substanzen

Biomarkers, TumorZinc Finger E-box-Binding Homeobox 1CadherinsZEB1 protein, humanCDH1 protein, humanAntigens, CD

Autor:innen und Institutionen

  • Anatomic Pathology, Department of Integrated Care Processes, University of Rome Tor Vergata, Viale Oxford 81, 00133 Rome, Italy.
  • Department of Laboratory Medicine, Tor Vergata University Hospital, 00133 Rome, Italy.
  • Department of Experimental Medicine, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy.
  • Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 1, 00133 Rome, Italy.

ORCID-Profile: Maria Giovanna Scioli, Tonia Cenci, Silvia Anzillotti, Alessandro Terrinoni, Anastasia De Luca, Augusto Orlandi

Zitieren

APA

Rapanotti, M. C., Cugini, E., Scioli, M. G., Cenci, T., Anzillotti, S., Puzzuoli, M., Terrinoni, A., Ferlosio, A., De Luca, A., & Orlandi, A. (2025). The Clinical Relevance of Epithelial-to-Mesenchymal Transition Hallmarks: A Cut-Off-Based Approach in Healthy and Cancerous Cell Lines. International Journal of Molecular Sciences, 26(8), 3617. https://doi.org/10.3390/ijms26083617

Vancouver

Rapanotti MC, Cugini E, Scioli MG, Cenci T, Anzillotti S, Puzzuoli M, et al. The Clinical Relevance of Epithelial-to-Mesenchymal Transition Hallmarks: A Cut-Off-Based Approach in Healthy and Cancerous Cell Lines. International Journal of Molecular Sciences. 2025;26(8):3617. doi:10.3390/ijms26083617

BibTeX
@article{Rapanotti2025,
  author = {Rapanotti, Maria Cristina and Cugini, Elisa and Scioli, Maria Giovanna and Cenci, Tonia and Anzillotti, Silvia and Puzzuoli, Martina and Terrinoni, Alessandro and Ferlosio, Amedeo and De Luca, Anastasia and Orlandi, Augusto},
  title = {The Clinical Relevance of Epithelial-to-Mesenchymal Transition Hallmarks: A Cut-Off-Based Approach in Healthy and Cancerous Cell Lines},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {8},
  pages = {3617},
  doi = {10.3390/ijms26083617}
}
Kostenlos starten →